Related Experiment Videos
Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation
Y I Miller1, Y Felikman, N Shaklai
1Sackler Institute of Molecular Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.
Archives of Biochemistry and Biophysics
|February 15, 1996
Summary
Hemoglobin and myoglobin are potent inducers of low-density lipoprotein (LDL) oxidation, promoting atherosclerosis. Antioxidants inhibit this hemoglobin-induced LDL oxidation, highlighting a key mechanism in disease development.
Area of Science:
- Biochemistry
- Cardiovascular Research
- Oxidative Stress
Background:
- Oxidative modification of low-density lipoprotein (LDL) is a key factor in atherosclerosis development.
- Hemoproteins like free hemin, hemoglobin, and myoglobin are implicated as promoters of LDL lipid oxidation.
Purpose of the Study:
- To compare the ability of free hemin and hemoproteins (hemoglobin, myoglobin, horseradish peroxidase) to induce peroxidation modification of apolipoprotein B (apo B).
- To investigate the mechanism of hemoglobin-induced LDL oxidation and the role of antioxidants.
Main Methods:
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to assess apo B modification.
- Determination of thiobarbituric acid-reactive substances to quantify lipid peroxidation products.
- Assessment of antioxidant inhibition, including Desferal.
Main Results:
- Hemoglobin and myoglobin showed high activity, comparable to free hemin, and significantly greater than horseradish peroxidase (HRP).
- Hemoglobin, myoglobin, and hemin induced apo B aggregation, while HRP caused fragmentation.
- Hemoglobin's reactivity occurred at low H2O2 concentrations and was inhibited by antioxidants.
Conclusions:
- Hemoglobin's high peroxidative reactivity stems from its ability to transfer oxidative equivalents from the heme site through the globin to LDL.
- This process triggers LDL protein and lipid oxidation, contributing to atherosclerosis preconditions.
- Antioxidants inhibit hemoglobin-induced LDL oxidation, suggesting therapeutic potential.